Immunodeficiency in Down's syndrome: relationship between presence of human thyroglobulin antibodies and HBsAg carrier status
- PMID: 144056
- DOI: 10.1007/BF00442195
Immunodeficiency in Down's syndrome: relationship between presence of human thyroglobulin antibodies and HBsAg carrier status
Abstract
The relationship between the presence of hepatitis B surface antigen (HBsAg) and antibodies to human thyroglobulin (HTgAb) has been studied in 110 subjects with Down's syndrome (DS) from 4 months to 50 years of age and in 122 controls carefully matched for sex, age and socio-environmental conditions. The overall percentage of HBsAg carriers was 22.7 in DS and 6.6 in controls and that of HTgAb-positive subjects was 41.8 in DS and 19.7 in controls. In DS the frequency of HTgAb-positive subjects was very high, even in the youngest age groups in which the percentage of HBsAg carriers was relatively low; the latter thereafter showed a marked increase with age. A positive association between the presence of HBsAg and HTgAb was found only in the oldest age group of DS subjects. It is thus concluded that in DS the high frequency of HTgAb cannot be attributed to chronic hepatitis B virus infection. On the contrary, the presence of HTgAb might well represent an early "marker" of immunodeficiency and increased susceptibility to infection with hepatitis B virus.
Similar articles
-
Immunological features of Down's syndrome: a review.J Intellect Disabil Res. 1993 Dec;37 ( Pt 6):543-51. doi: 10.1111/j.1365-2788.1993.tb00324.x. J Intellect Disabil Res. 1993. PMID: 8124000 Review.
-
Immunodeficiency in Down's syndrome. Titres of "natural" antibodies to E. coli and rabbit erythrocytes at different ages.Acta Paediatr Scand. 1978 Nov;67(6):705-8. doi: 10.1111/j.1651-2227.1978.tb16247.x. Acta Paediatr Scand. 1978. PMID: 152559
-
Hepatitis-B surface antigen and antibody: prevalence and persistence in institutionalized and noninstitutionalized persons.Public Health Rep. 1979 Jun;94(3):262-7. Public Health Rep. 1979. PMID: 156381 Free PMC article.
-
Down's syndrome and hepatitis: an evaluation of carrier status.J Am Dent Assoc. 1987 May;114(5):637-9. doi: 10.14219/jada.archive.1987.0146. J Am Dent Assoc. 1987. PMID: 2955013
-
Risks and prevention of severe RS virus infection among children with immunodeficiency and Down's syndrome.J Infect Chemother. 2014 Aug;20(8):455-9. doi: 10.1016/j.jiac.2014.05.001. Epub 2014 Jun 11. J Infect Chemother. 2014. PMID: 24929631 Review.
Cited by
-
Immunity in Down's syndrome.Eur J Pediatr. 1978 Apr 20;127(4):293-4. doi: 10.1007/BF00493546. Eur J Pediatr. 1978. PMID: 149663 No abstract available.
-
Cell-mediated cytotoxicity in Down syndrome: impairment of allogeneic mixed lymphocyte reaction, NK and NK-like activities.Eur J Pediatr. 1988 Oct;148(1):53-7. doi: 10.1007/BF00441815. Eur J Pediatr. 1988. PMID: 2973987
-
Immunodeficiency and syndromes: a nosographic approach.Eur J Pediatr. 1982 Jul;138(4):288-92. doi: 10.1007/BF00442498. Eur J Pediatr. 1982. PMID: 6215252 Review.
-
Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells.Clin Exp Immunol. 1984 Jul;57(1):220-6. Clin Exp Immunol. 1984. PMID: 6235075 Free PMC article.